To investigate the role of SMARCB1 loss in mediating tumor growth and metastasis, we used CRISPR/Cas9 to knockout (KO) SMARCB1 (from clone C16) in the human T24 BLCA cell line (Supplementary Fig. 3). Here, SMARCB1 is linked to bladder transitional cell carcinoma.